Sep 9, 2026 07:25PM
Sep 9, 2026 07:25PM
Jul 30, 2026 08:30AM
Jun 12, 2026 08:31AM
Jun 12, 2026 08:30AM
Jun 9, 2026 08:30AM
Jun 9, 2026 08:30AM Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria
Jun 3, 2026 06:56AM
Jun 2, 2026 08:00AM
Jun 2, 2026 08:00AM
Jun 1, 2026 08:30AM
Jun 1, 2026 08:30AM
May 5, 2026 08:30AM
Mar 26, 2026 04:30PM Disc Medicine completes enrollment in phase 3 bitopertin EPP trial
Mar 26, 2026 04:30PM
Mar 9, 2026 07:46AM
Mar 3, 2026 05:31PM
Feb 26, 2026 08:30AM
Feb 17, 2026 10:40AM
Feb 17, 2026 10:10AM
Feb 13, 2026 03:05PM FDA issues Complete Response Letter for Disc Medicine's bitopertin EPP treatment
Feb 13, 2026 03:04PM
Jan 29, 2026 04:49AM
Jan 15, 2026 12:00PM
Jan 15, 2026 10:38AM
Jan 15, 2026 06:02AM
Jan 12, 2026 08:33AM
Jan 12, 2026 08:30AM Disc Medicine Highlights Recent Achievements and Key Business Objectives and Milestones for 2026
Dec 19, 2025 04:08PM
Dec 19, 2025 03:26PM
Dec 19, 2025 02:14PM
Dec 8, 2025 04:16AM
Nov 6, 2025 08:30AM
Oct 20, 2025 06:30AM
Oct 20, 2025 06:30AM Disc Medicine Provides Update on Hematology Portfolio and Outlines Near-Term Business Objectives and Anticipated Milestones
Oct 17, 2025 08:21AM
Oct 17, 2025 06:59AM
Oct 17, 2025 06:46AM
Oct 17, 2025 05:17AM
Oct 17, 2025 05:14AM
Oct 16, 2025 05:36PM
Oct 16, 2025 05:35PM Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)
Sep 30, 2025 08:34AM
Sep 30, 2025 08:30AM
Aug 7, 2025 08:30AM
Jul 21, 2025 08:04AM
Jul 21, 2025 08:00AM
Jul 18, 2025 09:44AM
May 7, 2025 08:00AM Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update
Mar 3, 2025 06:55AM

334,268 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All